Serum eosinophil cationic protein as a potential biomarker for interleukin-5 antibody treatment in patients with severe uncontrolled eosinophilic asthma

M. Wilk (Mainz, Germany), B. Roland (Mainz, Germany), K. Stephanie (Mainz, Germany)

Source: International Congress 2018 – Biomarkers for evaluating asthma
Session: Biomarkers for evaluating asthma
Session type: Thematic Poster
Number: 1096
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Wilk (Mainz, Germany), B. Roland (Mainz, Germany), K. Stephanie (Mainz, Germany). Serum eosinophil cationic protein as a potential biomarker for interleukin-5 antibody treatment in patients with severe uncontrolled eosinophilic asthma. 1096

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: